Fairvalue-Calculator Fairvalue-Calculator

Infund Holding (002141) Fair Value & Analysis

Industrials · CN · Market cap 4.0B CNY

Price¥4.50
Fair Value¥0.7900
Upside-82.4%
Quality91/100
Evidence: High Range ¥0.5500 – ¥0.9000

Analysis

Infund Holding (002141) currently trades at ¥4.50, while our model-based Fair Value estimate is ¥0.7900 — implying the stock looks roughly 82.4% overvalued today. We read business quality at 91/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Infund Holding Co., Ltd. engages in the production and sales of copper clad laminates, feed, and veterinary vaccines and related technical services in China. The company offers animal nutrition; copper-clad, a plate-like material made of reinforcing materials, such as glass fiber cloth, paper base used in electrical appliances, home appliances, electronic information, involving industrial control, communication equipment, automotive electronics, security electronics, medical equipment, consumer electronics, computers and servers, transportation, aerospace and other fields. It provides vaccines for pigs, including blue ear, pseudorabies, porcine viral diarrhea and mycoplasma pneumonia diseases. In addition, it offers equity investment, asset management, external investment; and feed, biological vaccines. Infund Holding Co., Ltd. was founded in 1985 and is headquartered in Dongguan, China.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.